RGEN Repligen
$174.86 -7.73%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-7.73%
YTD
+19.80%
P/E
252.04
P/B
4.38
ROE
2%
Div yield
—
Beta
1.13
Market cap
$10.5B
RSI (14)
47
Next earnings
Oct 26, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$191.90
Close
$174.86
VWAP (n/a)
—
Day high
$194.36
Day low
$174.36
Volume
1.7M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Repligen Completes Acquisition of BioLife Solutions
Yahoo Finance · Oct 6
3 Unpopular Stocks Walking a Fine Line
Yahoo Finance · Sep 23
Freshworks Set to Join S&P SmallCap 600
Yahoo Finance · Oct 5
Freshworks stock climbs on S&P SmallCap 600 inclusion
Investing.com · Oct 5
BioLife Solutions Shareholders Approve Repligen Merger Agreement
Yahoo Finance · Oct 5
Why Are Freshworks (FRSH) Shares Soaring Today
Yahoo Finance · Oct 6
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Oct 6, 2026 View → 8-K Sep 15, 2026 View → 8-K Sep 8, 2026 View → 10-Q Jul 29, 2026 View → 8-K Jul 28, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell RGEN. Try it in the Lab to size a position and see the risk.